Quick Takeaways
- This page summarizes Jane Wright-Mitchell's Form 4 filing for Vera Therapeutics, Inc. (VERA).
- 2 reported transactions and 1 derivative row are listed below.
- Filing timestamp: 25 Mar 2026, 19:08.
Jane Wright-Mitchell - 23 Mar 2026 Form 4 Insider Report for Vera Therapeutics, Inc. (VERA)
- Role
- Chief Legal Officer
- Signature
- /s/ Joseph R. Young, Attorney-in-Fact
- Issuer symbol
- VERA
- Transactions as of
- 23 Mar 2026
- Net transactions value
- $0
- Form type
- 4
- Filing time
- 25 Mar 2026, 19:08:28 UTC
- Previous filing
- 18 Aug 2021
- SEC
- View on sec.gov
Quoteable Key Fact
"Jane Wright-Mitchell filed Form 4 for Vera Therapeutics, Inc. (VERA) on 25 Mar 2026."
What Changed
- Previous filing in this sequence was filed on 18 Aug 2021.
- Current net transaction value: $0.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Wright-Mitchell Jane | Chief Legal Officer | C/O VERA THERAPEUTICS, INC., 2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE | /s/ Joseph R. Young, Attorney-in-Fact | 25 Mar 2026 | 0001614568 |
Transactions Table
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | VERA | Class A Common Stock | Award | +42,403 | $0.000000* | 42,403 | 23 Mar 2026 | Direct | F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | VERA | Stock Option (right to buy) | Award | +56,850 | $0.000000* | 56,850 | 23 Mar 2026 | Class A Common Stock | 56,850 | $40.73 | Direct | F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Represents the number of shares of Class A Common Stock underlying the restricted stock units ("RSUs") granted under the Issuer's 2024 Inducement Plan. One-fourth of the RSUs, rounded to the nearest whole share, vest on each of May 20, 2027, 2028, 2029 and 2030, subject to the Reporting Person's continuous service through each vesting date. |
| F2 | 12/48ths of the shares subject to the stock option will vest and become exercisable on March 23, 2027, and 1/48th of the shares subject to the stock option will vest and become exercisable monthly on the same day of each month thereafter, subject to the Reporting Person's continuous service through each vesting date. |